Skip to main content

Find Clinical Trials

Home
Conditions
Acute Myeloid Leukemia With t(9;11)(p22.3;q23.3); MLLT3-KMT2A

Clinical trial condition

Acute Myeloid Leukemia With t(9;11)(p22.3;q23.3); MLLT3-KMT2A

Explore clinical trials studying Acute Myeloid Leukemia With t(9;11)(p22.3;q23.3); MLLT3-KMT2A. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies

Refine in advanced search Browse all conditions

Acute Myeloid Leukemia With t(9;11)(p22.3;q23.3); MLLT3-KMT2A trial results

Active, Not Recruiting

Nintedanib and Azacitidine in Treating Participants With HOX Gene Overexpression Relapsed or Refractory Acute Myeloid Leukemia

NCT03513484

Conditions: Acute Myeloid Leukemia With t(9;11)(p22.3;q23.3); MLLT3-KMT2A, FLT3 Internal Tandem Duplication, Fibroblast Growth Factor Basic Form Measurement, +9 more
Locations: Northwestern University Chicago, Illinois, United States

View Trial Details